PCOS to PMOS: What the Name Change Means for Billing, Coding & Clinical Practice
The international transition from PCOS to PMOS marks an important milestone in women's health, but changing a name is only the beginning. This webinar explores what happens after a name change, including impacts on ICD-10 coding, billing, electronic health records, payer policies, and clinical documentation. Participants will gain a practical understanding of the implementation process, expected timelines, and how to prepare their practices while maintaining compliant coding and reimbursement during the transition.
Moderator: Mindy S Christianson, MBA, MD, Cleveland Clinic
Speaker: Satu K Kuokkanen, MD, PhD, NYU Langone Health
Speaker: Kate D Schoyer, MD,Medical College of Wisconsin
Moderator: Mindy S Christianson, MBA, MD, Cleveland Clinic
Speaker: Satu K Kuokkanen, MD, PhD, NYU Langone Health
Speaker: Kate D Schoyer, MD,Medical College of Wisconsin
Learning Objectives:
- Describe the rationale for the international transition from polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) and summarize the anticipated implementation timeline.
- Explain how disease name changes are incorporated into healthcare systems, including updates to clinical terminology, ICD coding, electronic health records, payer policies, and reimbursement processes.
- Identify practical strategies for documenting, coding, and communicating with patients during the transition period while preparing their practices for future implementation of PMOS.
September 1, 2026
4:00 PM CT - 4:30 PM CT
4:00 PM CT - 4:30 PM CT
Don't miss out on this exciting webinar!
Register Now
Can't attend live? The recording will be available on ASRM Academy after the event.
Upcoming Virtual Sessions
September 1, 2026, PCOS to PMOS: What the Name Change Means for Billing, Coding & Clinical Practice
Learn how the PCOS-to-PMOS transition affects ICD-10 coding, billing, EHRs, payer policies, documentation, compliance, and reimbursement.
Topic Resources
View more on the topic of polyendocrine metabolic ovarian syndrome (PMOS)